US Broker Ratings

Clover Health Investments (CLOV): Investor Outlook Amid 52.25% Potential Upside

Clover Health Investments, Corp. (CLOV), a prominent player in the healthcare plans sector, is attracting considerable attention from investors, especially with a potential upside of 52.25% based on current analyst..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

Omnicell, Inc. (OMCL) Stock Analysis: 67% Potential Upside with Strong Buy Ratings

Omnicell, Inc. (OMCL), a leader in healthcare technology innovation, is capturing investor attention with its promising growth trajectory and substantial potential upside. With a market capitalization of $1.56 billion, Omnicell..

Apellis Pharmaceuticals, Inc. (APLS): Investor Outlook with a 90% Potential Upside

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a compelling player in the biotechnology sector, offering investors a unique opportunity to engage in innovative healthcare solutions. With a market capitalization of $2.25..

Addus HomeCare Corporation (ADUS) Stock Analysis: Potential 40% Upside Amid Robust Growth

Investors looking for opportunities in the healthcare sector might want to turn their attention to Addus HomeCare Corporation (NASDAQ: ADUS), a noteworthy player in the medical care facilities industry. With..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Impressive Potential with a 59% Upside

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) has been making waves in the healthcare sector, specifically within the realm of drug manufacturing for specialty and generic markets. With a market capitalization of..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring a 140% Upside Potential in Biotech

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands out in the biotechnology sector, offering investors a compelling opportunity with a potential upside of 140.56%. With a market capitalization of $3.63 billion, Crinetics..

Ascentage Pharma Group (AAPG) Stock Analysis: A Biotech with 120% Potential Upside

Ascentage Pharma Group International (AAPG) is capturing the attention of investors with its promising outlook in the biotechnology industry, particularly due to its potential upside of 120.17%. Headquartered in Suzhou,..

Evotec SE (EVO) Stock Analysis: Exploring a 120% Potential Upside Amidst Challenging Metrics

Evotec SE (EVO), a German-based drug discovery and development company, stands at a pivotal juncture in its financial trajectory. With a market capitalization of $852.63 million and a recent price..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Powerhouse with 22% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands as a formidable player in the biotechnology sector, captivating investor interest with its diverse portfolio of biopharmaceutical assets. Based in Jupiter, Florida, Ligand develops..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Unpacking the 252% Potential Upside for Investors

For investors with an eye on the biotechnology sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) stands out as a compelling prospect. With a market capitalization of $761.61 million, this San Diego-based..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Analyst Optimism Points to Significant Upside Potential

Dyne Therapeutics, Inc. (NASDAQ: DYN) is making waves in the biotechnology sector with its ambitious pipeline targeting neuromuscular diseases. Operating from Waltham, Massachusetts, this clinical-stage company is gaining attention for..

Sotera Health Company (SHC) Stock Analysis: 49.5% Potential Upside Captures Investor Attention

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector with its innovative sterilization solutions and lab testing services. As a key player in the Diagnostics & Research industry,..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Biotech Gem with 55.90% Potential Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) presents an intriguing opportunity for investors keen on the biotechnology sector. With a current market cap of $2.76 billion, this healthcare player is making significant..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Biotech Gem with a 288% Upside Potential

Janux Therapeutics, Inc. (NASDAQ: JANX) is making waves in the biotech sector with its innovative approach to cancer treatment and promising financial outlook. Based in San Diego, California, Janux is..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Strong Revenue Growth and Analyst Confidence Highlight Investment Potential

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands out in the healthcare sector with a robust portfolio in the medical instruments and supplies industry. With a market capitalization of $2.46 billion, this..

Harmony Biosciences Holdings (HRMY) Stock Report: Analyzing the 52.17% Potential Upside for Investors

Harmony Biosciences Holdings Inc. (NASDAQ: HRMY), a key player in the biotechnology sector, has emerged as a compelling investment opportunity for those keen on the dynamic healthcare industry. This commercial-stage..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unpacking the 100% Potential Upside

Alphatec Holdings, Inc. (NASDAQ: ATEC), a dynamic player in the healthcare sector, is making waves in the medical devices industry. With a focus on innovative technologies for spinal surgery, this..

DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Unpacking a 25.96% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the medical instruments and supplies industry, is drawing attention with its substantial potential upside of 25.96%. This potential growth, alongside a..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 41.62% Potential Upside in the Diagnostics Sector

For investors with a keen interest in the healthcare sector, Veracyte, Inc. (VCYT) offers a compelling opportunity with a noteworthy potential upside of 41.62%. Specializing in diagnostics and research, Veracyte..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds